In particular, increased plasma levels of this metabolite have been described for MELAS, MERRF, mtDNA depletion/deletions diseases, infantile-onset spinocerebellar ataxia (IOSCA), and respiratory chain deficiencies [19, 25, 26]. This evidence concerns the gene MT-TK and MELAS.